Genentech to Present New Data at ASCO 2026, Reinforcing Giredestrant's Potential to Transform the Treatment Paradigm in Early Breast Cancer
FDA Approves Genentech's Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment
Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026
Genentech's Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS
Genentech's Enspryng Reduces Risk of Relapses by 68% Demonstrating Potential to Become First Treatment for MOGAD
Gold Runner Exploration Announces Mobilization Date and Exploration Program Update at Golden Girl Property, Golden Triangle B.C.
QIMC Reports 10.77% Hydrogen Mud-Gas Reading at West-Advocate - Five Stacked %-Level Readings in a 69-Metre Methane-Free Hydrogen-Rich Interval in Hole DDH-26-03, West Advocate, Nova Scotia
Torrent Capital Reports Q1 2026 Financial Results; Provides Preliminary April Net Asset Value and Portfolio Update
